Skip to main content

Adial Pharmaceuticals, Inc.

ADIL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001513525

In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.

Superinvestors holding ADIL, Q2 2026

See all superinvestors

No superinvestor reported holding ADIL in Q2 2026.